# Bepirovirsen Liver Biopsy Study

> **NCT07696520** · PHASE2 · NOT_YET_RECRUITING · sponsor: **National University Health System, Singapore** · enrollment: 30 (estimated)

## Conditions studied

- HEPATITIS B CHRONIC
- Hepatitis B Chronic Infection

## Interventions

- **DRUG:** Bepirovirsen
- **PROCEDURE:** Liver biopsy
- **PROCEDURE:** Optional Liver biopsy

## Key facts

- **NCT ID:** NCT07696520
- **Lead sponsor:** National University Health System, Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2027-12-30
- **Final completion:** 2028-04-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-07-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07696520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07696520, "Bepirovirsen Liver Biopsy Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07696520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*